A Phase I Study of the Co-administration of VLX-1005 and Argatroban in Healthy Human Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The study is designed to characterize the safety and tolerability of VLX-1005 and argatroban administered intravenously, either alone or in combination; and the pharmacokinetics and pharmacodynamics and potential interaction of both agents in a population of healthy subjects.
Epistemonikos ID: 14b99b8edb3f175696a57dee8de36086c7bf16e6
First added on: May 13, 2024